Cardiff Oncology (NASDAQ:CRDF – Get Rating) had its price objective dropped by investment analysts at Piper Sandler from $20.00 to $7.00 in a report released on Friday, The Fly reports. Piper Sandler’s price objective points to a potential upside of 442.64% from the stock’s previous close. A number of other brokerages have also recently issued […]
Related Keywords
California , United States , Piper Sandler , Robertw Baird , Cardiff Oncology Inc , Geode Capital Management , Life Insurance Co , Zacks Investment Research , Caxton Corp , Janus Henderson Group , Cardiff Oncology , Get Rating , Investment Research , Sigma Advisers , Henderson Group , Capital Management , Polo Like Kinase , Nasdaq Crdf , Acrdf , Medical , Lower Price Target ,
comparemela.com © 2020. All Rights Reserved.